Magwe, E. (2025). Prevalence and Determinants of HIV Infections among Pregnant Women Attending Antenatal Clinics in Iringa Municipality, Tanzania. Afro-Egyptian Journal of Infectious and Endemic Diseases, 15(2), 169-178. doi: 10.21608/aeji.2025.344033.1439
Edward Augustine Magwe. "Prevalence and Determinants of HIV Infections among Pregnant Women Attending Antenatal Clinics in Iringa Municipality, Tanzania". Afro-Egyptian Journal of Infectious and Endemic Diseases, 15, 2, 2025, 169-178. doi: 10.21608/aeji.2025.344033.1439
Magwe, E. (2025). 'Prevalence and Determinants of HIV Infections among Pregnant Women Attending Antenatal Clinics in Iringa Municipality, Tanzania', Afro-Egyptian Journal of Infectious and Endemic Diseases, 15(2), pp. 169-178. doi: 10.21608/aeji.2025.344033.1439
Magwe, E. Prevalence and Determinants of HIV Infections among Pregnant Women Attending Antenatal Clinics in Iringa Municipality, Tanzania. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2025; 15(2): 169-178. doi: 10.21608/aeji.2025.344033.1439
Prevalence and Determinants of HIV Infections among Pregnant Women Attending Antenatal Clinics in Iringa Municipality, Tanzania
Department of Pharmaceutical Sciences, Institute of Health and Allied Sciences, Ruaha Catholic University, P.O. Box 774 Iringa, Tanzania.
Abstract
Background and study aim: The Human Immunodeficiency Virus (HIV) prevalence among pregnant women in Sub-Saharan Africa is a significant public health issue, with the region accounting for about 85% of global cases. In Tanzania, the prevalence among pregnant women has shown varying trends over the years, around 7% to 5.6%. This study assessed HIV prevalence among pregnant women attending antenatal clinics in the Iringa region of Tanzania and identified the determinants associated with the prevalence to inform targeted public health interventions. Patients and Methods: This study was conducted in Iringa Municipality, Tanzania, and employed a quantitative cross-sectional design from June 12 to July 15, 2024. The sample comprised 545 pregnant women selected from 12 public healthcare facilities. Data was collected from antenatal clinic cards and analyzed using the Statistical Package for the Social Sciences (SPSS) to determine frequencies, percentages, and statistical relationships. Results: The study revealed a moderately high HIV prevalence of 2.4% among pregnant women, with the majority (97.6%) being HIV-negative. Higher prevalence rates were identified in women aged 20-35, married women, secondary education level, and low income. However, all variables were not statistically significant with HIV prevalence (P-value > 0.05). Conclusion: The moderately high HIV prevalence reported among pregnant women in this study remains a significant public health concern, underscoring the critical need for targeted interventions for this vulnerable population.
Highlights
The research indicated a moderately high HIV prevalence of 2.4% among pregnant women attending antenatal clinics. In contrast, the majority of participants (97.6%) tested HIV-negative, suggesting a relatively low prevalence when compared to the recently reported figures from the general population in the Iringa region and across Tanzania.
Higher HIV prevalence rates were observed in specific demographic groups, particularly among women aged 20-35, married women, those with secondary education, and low income.
The results underscore the ongoing public health concern regarding HIV among pregnant women in Iringa, highlighting the need for targeted health interventions to address the vulnerabilities of this population.
The prevalence of Human Immunodeficiency Virus (HIV) among pregnant women in Sub-Saharan Africa remains a significant public health concern, with the region accounting for a substantial proportion of the global burden of HIV. As of recent estimates, approximately 85% of all pregnant women living with HIV worldwide reside in this region [1]. The Joint United Nations Programme on HIV/AIDS (UNAIDS) report from 2017 indicated that the overall prevalence of HIV among individuals aged 15-49 in Sub-Saharan Africa was approximately 12.5% [1].
This statistic underscores the critical need for targeted interventions and healthcare services tailored to this vulnerable population. In Southern Sub-Saharan Africa, HIV prevalence rates among pregnant women are particularly alarming, often exceeding 20% in several countries [2]. Furthermore, a systematic review highlighted that Southern Africa bears a disproportionate burden of sexually transmitted infections (STIs), which can exacerbate the risks associated with HIV during pregnancy [3]. The pooled prevalence of STIs in this region is notably high, further complicating the health outcomes for pregnant women living with HIV.[3]
The younger women, those who have not disclosed their HIV status to their partners, and those not on antiretroviral therapy (ART) are at a higher risk of having unsuppressed viral loads [4]. This situation is critical as unsuppressed viral loads can lead to increased mother-to-child transmission of HIV, which remains a significant concern in the region [5]. The effectiveness of ART in preventing vertical transmission has been well-documented; however, barriers to adherence, such as stigma and lack of partner support, continue to hinder progress [6]. Moreover, socio-behavioral factors like gender inequality, poverty, partner violence, food insecurity, and cultural norms significantly influence HIV prevalence among pregnant women in Sub-Saharan Africa [7,8].
In Tanzania, the prevalence of HIV among pregnant women has shown varying trends over the years, reflecting both the impact of public health interventions and the ongoing challenges faced in combating the epidemic [9]. The prevalence of HIV among pregnant women was reported to be around 7% in specific municipalities with higher rates of transmission [10]. For over two decades, the HIV sentinel surveillance (HSS) among pregnant women attending antenatal clinics (ANC) has provided estimates of the burden and trend of HIV infections in Tanzania [11]. Six rounds of HSS have been done since 2000 and results indicate a decline in the prevalence of HIV infections among pregnant women in Tanzania from 9.6% in 2001 to 5.6% in 2011 [11,12]. Furthermore, the mentioned longitudinal study showed a decline in HIV prevalence among pregnant women in Tanzania from 2001 to 2011, attributed to effective public health initiatives like ART and prevention of mother-to-child transmission (PMTCT) programs [11]. Despite the progress made, challenges persist. A study highlighted that a significant proportion of HIV-positive pregnant women still face barriers to accessing ART, which is vital for reducing the risk of vertical transmission [12]. Additionally, the presence of co-infections, such as syphilis, which was found to affect 1.4% of pregnant women in Tanzania, poses additional risks for adverse pregnancy outcomes and complicates the management of HIV [13].
In the context of general public health, the Iringa region has consistently demonstrated high prevalence rates, as indicated in the reports from 2016-2017, which recorded a rate of 11.3%, and from 2022-2023, which noted a rate of 11.1%. This positions Iringa as the second-highest region after Njombe in both assessments [14]. Consequently, this study focused on assessing the prevalence of HIV and its determinants among pregnant women attending antenatal clinics in Iringa Municipality, Tanzania.
METHODS
Study area
The area of focus for this study is Iringa Municipality, located in the Iringa region of Tanzania. As the administrative capital, Iringa Municipal Council is one of five councils in the region, distinguished by its urban characteristics. The other councils include the Iringa District Council, Kilolo District Council, Mufindi District Council, and Mafinga Town Council. Iringa Municipality is bordered by the Iringa Rural and Kilolo district councils and is positioned between latitudes 7.7° and 7.875° south of the Equator, and longitudes 35.620° and 35.765° east of the Greenwich Meridian. The 2022 census reported that the municipality has a population of 202,490 residents [15,16].
Study design
The study conducted from June 12 to July 15, 2024, employed a quantitative cross-sectional analytical design to rigorously assess the prevalence of HIV and its associated factors among pregnant women receiving antenatal care in Iringa Municipality, Tanzania. This methodological approach facilitated the collection and analysis of data at a single time point, thereby enhancing the understanding of the epidemiological characteristics of HIV in this specific population.
Study population
The research targeted pregnant women who utilized antenatal care services in Iringa Municipality, Tanzania. Participants were required to meet specific inclusion criteria, which stipulated that they must be pregnant, have resided in Iringa Municipality for a minimum duration of six months, and be willing to provide informed consent for the study. Exclusion criteria encompassed individuals who were unable to provide informed consent due to cognitive or psychological impairments, as well as pregnant women who were transient visitors to the antenatal clinic without having established residency in the municipality for at least six months.
Sampling and sample size
Due to the limited availability of public hospitals and health centers, a deliberate choice was made to include all two available hospitals and four health centers in the municipality, along with a random selection of six public dispensaries. This method led to a total of twelve public healthcare facilities taking part in the study. Pregnant women were subsequently chosen at random from each facility. Cochran's formula was used to determine the sample size for the study.
Where; N = Minimum sample size
Z = Constant, standard normal deviation (1.96 for 95% confidence level)
P = Estimated proportion of the population (50% or 0.5) to maximize sample size in the absence of precise prevalence data
d = acceptable margin of error (4.2% or 0.042)
Therefore, the study in Iringa Municipality involved a total sample size of 545 pregnant women.
Data collection
All socio-demographic characteristics and HIV status data were recorded from the antenatal clinic cards of pregnant women during their current visits.
Data analysis
Data analysis was performed using version 26 of the Statistical Package for Social Sciences (SPSS), emphasizing frequencies and percentages to provide a foundational understanding of the dataset. Bivariate analyses, specifically chi-square tests, and p-values, were employed to identify significant associations between the predictor variables and HIV prevalence. However, further multivariate logistic regression was not performed due to the absence of significant relationships in the bivariate analysis and the presence of sparse data. The sparse data included several categories with either zero or very few positive cases of HIV, resulting in unstable and unreliable estimates. Consequently, the analysis concentrated on bivariate relationships to provide insights while acknowledging this limitation.
Definitions and scoring
The HIV prevalence serves as a proxy for estimating the overall HIV burden within the pregnant women population. For the general population, a prevalence rate of P ≥ 5% is classified as high, P = 1-4.9 as moderately high prevalence, and P < 1% as low prevalence [17].
RESULTS
Socio-demographic characteristics of pregnant women
A significant majority of the participants, totaling 440 (80.7%) women, were between 20 and 35 years, typically considered the biologically optimal age for pregnancy. Conversely, there were 67 (12.3%) women who were under 20 years old, indicating instances of adolescent pregnancies, while 38 (7%) women were above 35 years, representing cases of advanced maternal age. Regarding marital status, a substantial portion of the participants, 415 (76.1%) women, were married, whereas 130 (23.9%) were unmarried. Concerning educational attainment, it was found that 376 (69%) women had completed secondary education, followed by 89 (16.3%) women who had completed only primary education. The data on income levels reveal financial challenges these women face, with 378 (69.4%) classified as low-income earners and 160 (29.4%) identified as middle-income earners. Occupationally, the largest subgroup consisted of petty business workers, numbering 284 (52.1%), followed by homemakers at 95 (17.4%). Regarding the stages of pregnancy, 202 (37.1%) women were in their first trimester, while 277 (50.8%) women were in their second trimester, as detailed in Table 1.
Prevalence of HIV infections among pregnant women
The data presented illustrates the prevalence of HIV infections among pregnant women, with a focus on their HIV status. The results indicate that 2.4% of the sampled population is HIV positive, signifying a moderately high prevalence of the virus within this demographic. Despite this, a substantial majority, 97.6%, of the population reported being HIV-negative, highlighting that a predominant number of pregnant women do not carry the virus, as shown in the Figure.
Bivariate analysis of HIV prevalence determinants among pregnant women
In the bivariate analysis of HIV prevalence determinants among pregnant women, specific categories demonstrated the highest prevalence of HIV-positive cases: the age group of 20-35 years had 13 (2.4%) cases, while other categories had no cases; married pregnant women accounted for 11 (2.0%) cases. The secondary education group reported 8 (1.5%) cases, the low-income category noted 7 (1.3%), while the petty business occupation revealed 10 (1.8%) positive cases. Additionally, trimester one recorded 7 (1.3%), and the over-one parity group indicated 8 (1.5%) positive cases. Despite these observed variations in prevalence among the different predictor variables, the statistical analysis confirms that none of these associations are significant, as indicated by p-values (>0.05), indicating that assessed predictors do not substantially influence HIV positivity among pregnant women, as described in Table 2. Due to the lack of significant relationships identified in the bivariate analysis among all predictors, the decision was made to forego further logistic regression. This choice was influenced by unexpected values resulting from zeros and the limited number of positive cases across several categories.
Table (1): Socio-demographic characteristics of pregnant women (N = 545)
Socio-demographic characteristics
Frequency (n)
Percent (%)
Age (Years)
Below 20
67
12.3
20-35
440
80.7
Above 35
38
7.0
Marital status
Married
415
76.1
Unmarried
130
23.9
Education level
No formal education
8
1.5
Primary
89
16.3
Secondary
376
69.0
College or university
72
13.2
Income per month (Tsh)
Low (Less than 300,000)
378
69.4
Middle (300,000 – 1,000,000)
160
29.4
High (More than 1,000,000)
7
1.3
Occupation
Homemaker
95
17.4
Formal employment
86
15.8
Petty business
284
52.1
Farmer
80
14.7
Trimester
One
202
37.1
Two
277
50.8
Three
66
12.1
Parity
One
238
43.7
Over one
307
56.3
First pregnancy’s age (Years)
Below 20
150
27.5
20-35
393
72.1
Above 35
2
0.4
Table (2): Bivariate analysis of HIV prevalence determinants among pregnant women (N = 545)
Predictor variables
HIV status
Chi-
square
P-
Value
Positive
Negative
Age (Years)
Below 20
0 (0.0)
67 (12.3)
20-35
13 (2.4)
427 (78.3)
3.178
0.204
Above 35
0 (0.0)
38 (7.0)
Marital status
Married
11 (2.0)
404 (74.1)
0.526
0.468
Unmarried
2 (0.4)
128 (23.5)
Education level
No formal education
1 (0.2)
7 (1.3)
Primary
3 (0.6)
86 (15.8)
4.3
0.231
Secondary
8 (1.5)
368 (67.5)
College or university
1 (0.2)
71 (13.0)
Income per month (Tsh)
Low (Less than 300,000)
7 (1.3)
371 (68.1)
Middle (300,000 – 1,000,000)
6 (1.1)
154 (28.3)
1.913
0.384
High (More than 1,000,000)
0 (0.0)
7 (1.3)
Occupation
Homemaker
2 (0.4)
93 (17.1)
Formal employment
1 (0.2)
85 (15.6)
4.112
0.25
Petty business
10 (1.8)
274 (50.3)
Farmer
0 (0.0)
80 (14.7)
Trimester
One
7 (1.3)
195 (35.8)
Two
5 (0.9)
272 (49.9)
1.627
0.443
Three
1 (0.2)
65 (11.9)
Parity
One
5 (0.9)
233 (42.8)
0.147
0.702
Over one
8 (1.5)
299 (54.9)
First pregnancy’s age (Years)
Below 20
3 (0.6)
147 (27.0)
20-35
10 (1.8)
383 (70.3)
0.187
0.911
Above 35
0 (0.0)
2 (0.4)
DISCUSSION
This recent study indicated a moderately high prevalence of 2.4% among pregnant women in the Iringa region, which is lower than the rates observed in several other countries and previous studies conducted in Tanzania. In Tanzania, a sentinel surveillance report indicated an HIV prevalence of 5.9% among pregnant women attending antenatal clinics, which is significantly higher than the reported 2.4% in this study [12]. Another notable study by Ng’Wamkai et al. reported an HIV prevalence of 5.0% among pregnant women in rural Mwanza, Tanzania, which is significantly higher than the prevalence observed in this recent study [18]. The findings are consistent with earlier research by Manyahi et al., which documented a prevalence of 5.6% among pregnant women in both urban and rural settings across Tanzania [11]. The consistency of these higher prevalence rates indicates ongoing challenges in controlling HIV transmission among pregnant women in Tanzania.
In contrast, a study by Malima et al. found a lower prevalence of 2.6% among pregnant women in a rural setting in Northern Tanzania, closer to the 2.4% figure from this study [18]. This suggests that while some regions in Tanzania experience higher rates of HIV, others, including Iringa, may have successfully implemented interventions that have led to lower prevalence rates. The current study reveals a prevalence rate of 2.4%, which is significantly lower than the reported general population prevalence of 11.1% for the Iringa region, the second highest in the country [14]. This discrepancy underscores the need for further investigation into HIV prevalence across both rural and urban settings within the region, as well as an evaluation of the effectiveness of recent interventions implemented in the region.
Outside Tanzania, a systematic review in Nigeria highlighted a much higher prevalence of HIV among pregnant women, with rates reaching up to 11.5% in Abuja and even higher in some regions, such as 26% in Lusaka, and Zambia [19,20]. A study conducted in Cameroon revealed a prevalence rate of 10.3% among pregnant women, which is significantly higher than the figures reported in Tanzania [21]. This discrepancy underscores the notion that, while Tanzania has made meaningful progress in reducing HIV prevalence among pregnant women, other regions continue to encounter considerable challenges. Conversely, in Ethiopia, the prevalence among pregnant women was approximately 5.6%, which aligns closely with those observed in Tanzania [22].
Furthermore, when comparing Tanzania's prevalence with other countries outside Africa, such as Brazil, where the prevalence among pregnant women was reported at 0.38%, it becomes evident that Tanzania's rates are still relatively high [23]. Brazil's lower prevalence could be attributed to different public health strategies and socio-economic factors that influence HIV transmission dynamics.
Despite the lack of significant association in the bivariate analysis of HIV prevalence determinants among pregnant women, the age group of 20-35 years, married pregnant women, secondary education group, low-income category, and petty business occupation reported a higher prevalence of HIV-positive cases compared to other categories. Another study conducted in Dar es Salaam, Tanzania, reported a significant seroprevalence of HIV among pregnant women, with those aged 20-35 being particularly affected [11]. This aligns with findings from broader sub-Saharan Africa, where similar trends have been observed, suggesting that younger and middle-aged pregnant women are at a heightened risk of HIV infection due to various socio-economic and biological factors [24,25]
Moreover, marital status has been identified as a significant determinant of HIV prevalence. Married pregnant women often have higher rates of HIV, which may be attributed to factors such as limited sexual autonomy and increased exposure to HIV through stable partnerships [26]. This observation is corroborated by research from South Africa, where married women attending antenatal clinics exhibited a higher prevalence of HIV compared to their unmarried counterparts [27]. The implications of these findings suggest that interventions targeting married women in this age group could be crucial in reducing HIV transmission rates.
Education level significantly impacts HIV prevalence among pregnant women. Research shows that individuals with secondary education may engage in higher-risk behaviors, increasing HIV exposure [22]. This trend is observed across Africa, where educational disparities affect HIV knowledge and risk behaviors [26]. Also, studies revealed that pregnant women in low-income, especially those in petty business occupations, have higher HIV rates due to economic vulnerability, which increases transactional sex and limits healthcare access [11,28]. Tailored interventions are needed to reduce HIV transmission in these groups effectively.
Recommendations:
Develop and implement targeted educational programs aimed at demographic groups with the highest prevalence of HIV, which should provide information about HIV transmission, prevention, and safe practices while encouraging routine testing to maximize public health impact. Increase access to healthcare and support services for low-income pregnant women who are at a higher risk, including subsidized healthcare and access to educational material on safe practices. Engage community health workers to conduct outreach and education in low-income areas, focusing on the importance of regular health check-ups, HIV testing, and the benefits of early detection and treatment. Establish a robust monitoring and evaluation system to track the effectiveness of implemented programs and make data-driven adjustments as needed to ensure that the program meets the needs of the population and addresses any emerging trends.
CONCLUSION
The analysis of HIV prevalence among pregnant women reveals a moderately high overall infection rate of 2.4%, indicating that the vast majority of this demographic is HIV-negative. Certain categories, including women aged 20 to 35, married women, and secondary education level, demonstrated elevated rates of HIV prevalence. However, bivariate statistical analysis indicated that the associations observed are not statistically significant. The absence of meaningful correlations among the various predictors suggests that factors other than those analyzed may be influencing HIV prevalence in pregnant women. Consequently, it is essential to explore additional variables or broader studies to gain a more comprehensive understanding of HIV risk in this population and effectively address public health concerns.
Acknowledgement:
The authors thank the Zanzibar Health Research Institute (ZHRI) for granting ethical clearance to carry out this study and the participants whose involvement facilitated the research.
Ethical approval:
Ruaha Catholic University (RUCU) provided ethical clearance for this research, documented under reference RU/RPC/RP/2024/12. The office of the director of the Iringa Municipal Council, in collaboration with the district medical officer's office and the medical officer in charge at the facility level, provided permission for data collection. Informed consent was secured from all study participants. All collected data were handled with utmost confidentiality, ensuring no personal information was disclosed.
Conflict of Interest Statement: There are no conflicts of interest in this study.
Funding Sources: There is no funding support associated with this study.
Acknowledgments: The author expresses heartfelt gratitude to Ruaha Catholic University (RUCU) for granting ethical clearance for this study. Additionally, sincere thanks are directed to the office of the Director of the Iringa Municipal Council, the District Medical Officer’s Office, healthcare professionals and administrators at the facilities, as well as all participants who contributed to this research.
References
Jaén-Sánchez N, González-Azpeitia G, Santana P, Saavedra-Sanjuán E, Manguiza A, Manwere N, et al. Adolescent motherhood in Mozambique. Consequences for pregnant women and newborns. Plos One 2020;15(6): e0233985.
Kafeero H, Ndagire D, Ocama P, Walusansa A, Sendagire H. Seroprevalence of Human Immunodeficiency Virus-Hepatitis B Virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis. Virol J 2020;17(1).
Nyemba DC, Haddison EC, Wang C, Johnson LF, Myer L, Davey DJ. Prevalence of curable STIs and bacterial vaginosis during pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect 2022;98(7):484-491.
Schrubbe L, Stöckl H, Hatcher A, Marston M, Kuchukhidze S, Calvert C. Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveys. AIDS 2022;37(4):659-669.
Astawesegn F, Stulz V, Conroy E, Mannan H. Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in sub-Saharan Africa. Evidence from panel data analysis. BMC Infect Dis 2022;22(1).
Schrubbe L, Stöckl H, Hatcher A, Calvert C. Sexual violence and antiretroviral adherence among women of reproductive age in African population-based surveys: the moderating role of the perinatal phase. J Int AIDS Soc 2023;26(6).
Soto‐Ruiz N, Arregui-Azagra A, Martín-Rodríguez L, Elizalde-Beiras I, Saralegui-Gainza A, Escalada-Hernández P. HIV incidence among women in sub-Saharan Africa: a time trend analysis of the 2000–2017 period. J Assoc Nurses AIDS Care 2021;32(6):662-662.
Willie T, Kershaw T, Callands T. Examining relationships of intimate partner violence and food insecurity with HIV-related risk factors among young pregnant Liberian women. AIDS Care 2018;30(9):1156-1160.
Bull S, Thomas D, Nyanza E, Ngallaba S. Tanzania health information technology (T-HIT) system: Pilot test of a tablet-based system to improve prevention of mother-to-child transmission of HIV. JMIR Mhealth Uhealth. 2018;6(1):e16.
Kalolella A. The human immunodeficiency virus seroprevalence and AIDS-related opportunistic infection patterns among women with the retained placenta in eastern Tanzania. Texila Int J Nurs 2017;3(2):220-229.
Manyahi J, Jullu B, Abuya M, Juma J, Kilama B, Sambu V, et al. The decline in the prevalence of HIV among pregnant women attending antenatal clinics in Tanzania, 2001-2011. Tanzan J Health Res 2017;19(2).
Mboya E, Mizinduko M, Balandya B, Mushi J, Sabasaba A, Amani D, et al. HIV burden and the global fast-track targets progress among pregnant women in Tanzania calls for intensified case-finding analysis of 2020 antenatal clinics HIV sentinel site surveillance. Plos One 2023;18(10):e0285962.
Sunguya B, Mboya E, Mizinduko M, Balandya B, Sabasaba A, Amani D, et al. Epidemiology of syphilis infections among pregnant women in Tanzania: analysis of the 2020 national representative sentinel surveillance. Plos One 2023;18(8): e0285069.
The Tanzania HIV Impact Survey 2022-2023 (THIS 2022-2023). Available at. https://www.moh.go.tz/storage/app/uploads/public/656/9d9/722/6569d97229c72559818577.pdf. (Accessed July 30, 2024).
Ntungwa HO, EMM EM, ASK AS. The knowledge, attitude, and practices toward toxoplasmosis among community members in Iringa Municipal, Tanzania. East African Journal of Science, Technology and Innovation. 2024;5(3):1-21.
Mbunda C, Phillipo F, Nzali A. Institutional barriers to women contesting for political positions, a case of Iringa Municipality in Tanzania. Arch Curr Res Int. 2023;23(8):1-10.
Adetunji J. Trends in under-5 mortality rates and the HIV/AIDS epidemic. Bull World Health Organ. 2000;78:1200-6.
Ng’wamkai G, Msigwa KV, Chengula D, Mgaya F, Chuma C, Msemwa B, et al. Treponema pallidum infection predicts sexually transmitted viral infections (hepatitis B virus, herpes simplex virus-2, and human immunodeficiency virus) among pregnant women from rural areas of Mwanza region, Tanzania. BMC Pregnancy Childbirth. 2019;19(1).
Okonko I, Osadebe A, Onianwa O, Okereke S. Prevalence of HIV in a cohort of pregnant women attending a tertiary hospital in Ibadan, Nigeria. Immunol Infect Dis. 2019;7(1):7-12.
Ozim C, Mahendran R, Amalan M, Puthussery S. Prevalence of human immunodeficiency virus (HIV) among pregnant women in Nigeria: a systematic review and meta-analysis. BMJ Open 2023;13(3): e050164.
Sama C, Feteh V, Tindong M, Tanyi T, Bihle N, Angwafo F. Prevalence of maternal HIV infection and knowledge on mother-to-child transmission of HIV and its prevention among antenatal care attendees in a rural area in northwest Cameroon. Plos One 2017;12(2):e0172102.
Geremew D, Tajebe F, Ambachew S, Endalamaw A, Eshetie S. Seroprevalence of HIV among pregnant women in Ethiopia: a systematic review and meta-analysis. BMC Res Notes 2018;11(1).
Pereira G, Sabidó M, Caruso A, Oliveira S, Mesquita F, Benzaken A. HIV prevalence among pregnant women in Brazil: a national survey. Rev Bras Ginecol Obstet. 2016;38(08):391-398.
Eaton J, Rehle T, Jooste S, Nkambule R, Kim A, Mahy M, et al. Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa. AIDS 2014;28(Supplement 4): S507-S514.
Kharsany A, Fröhlich J, Yende‐Zuma N, Mahlase G, Samsunder N, Dellar R, et al. Trends in HIV prevalence in pregnant women in rural South Africa. JAIDS J Acq Imm Def. 2015;70(3):289-295.
Hoque M, Hoque M, Hal G, Buckus S. Prevalence, incidence and seroconversion of HIV and syphilis infections among pregnant women of South Africa. S Afr J Infect Dis. 2021;36(1).
Fatti G, Shaikh N, Eley B, Jackson D, Grimwood A. Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: a cohort study at public facilities in the Nelson Mandela Bay Metropolitan District, Eastern Cape, South Africa. S Afr Med J. 2014;104(12):874.
Ohihoin A, Musa J, Sagay A, Ujah I, Herbertson E, Ocheke A. Prevalence and determinants of anemia among HIV positive pregnant women attending antenatal clinic at the Jos University Teaching Hospital, Jos, North-Central Nigeria. Br J Med Med Res 2014; 4(34): 5348-5356.